Bipolar Depression Study – Marietta, GA
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating The Efficacy, Safety And Tolerability Of Cariprazine In Patients With Bipolar I Depression
If you are between the ages of 18 and 65 and have been diagnosed and treated for Bipolar Disorder Type 1 in the past and are currently experiencing a depressive disorder you may qualify for a clinical study.
Northwest Behavioral Research Center is evaluating the effectiveness and safety of a study medication for Bipolar Depression in our Marietta office. Study evaluation, study medication, and study related care is at no charge. You may receive compensation for time and travel.
Please call 770-422-2846
Email us at [email protected]